Loading...
Source
Literatura:
Olivia Dean O. Giorlando F. Berk M. i in. 2011. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
J Psychiatry Neurosci. 2011 Mar; 36(2): 78–86. doi: 10.1503/jpn.100057
Hashimoto K, Tsukada H, Nishiyama S. 2004. Protective Effects of N-acetyl-L-cysteine on the Reduction of Dopamine Transporters in the Striatum of Monkeys Treated with Methamphetamine. Neuropsychopharmacology. 2004 Nov;29(11):2018-23.
Kalimeris K1, Briassoulis P2, Ntzouvani A3. 2006. N-acetylcysteine ameliorates liver injury in a rat model of intestinal ischemia reperfusion. J Surg Res. 2016 Dec;206(2):263-272. doi: 10.1016/j.jss.2016.08.049. Epub 2016 Aug 19
Minarini A1, Ferrari S1, Galletti M1. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
Expert Opin Drug Metab Toxicol. 2016 Nov 2:1-14
Literatura:
Olivia Dean O. Giorlando F. Berk M. i in. 2011. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
J Psychiatry Neurosci. 2011 Mar; 36(2): 78–86. doi: 10.1503/jpn.100057
Hashimoto K, Tsukada H, Nishiyama S. 2004. Protective Effects of N-acetyl-L-cysteine on the Reduction of Dopamine Transporters in the Striatum of Monkeys Treated with Methamphetamine. Neuropsychopharmacology. 2004 Nov;29(11):2018-23.
Kalimeris K1, Briassoulis P2, Ntzouvani A3. 2006. N-acetylcysteine ameliorates liver injury in a rat model of intestinal ischemia reperfusion. J Surg Res. 2016 Dec;206(2):263-272. doi: 10.1016/j.jss.2016.08.049. Epub 2016 Aug 19
Minarini A1, Ferrari S1, Galletti M1. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
Expert Opin Drug Metab Toxicol. 2016 Nov 2:1-14